Navigation Links
Dynatronics Will Request Hearing with Nasdaq Regarding Listing Status
Date:11/8/2012

SALT LAKE CITY, Nov. 8, 2012 /PRNewswire/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced that on November 7, 2012, the Company received a Nasdaq Staff Determination Letter indicating that the Company has not complied with the $1.00 minimum bid rule for continued listing set forth in Listing Rule 5550(a)(2) and faces delisting from the Nasdaq Capital Market at the opening of business on November 16, 2012, unless the Company requests an appeal of the determination by the staff.

The Company will request an appeal of the delisting determination pursuant to procedures available under the Nasdaq Listing Rules.  The hearing panel is authorized to grant additional time to regain compliance, if the panel deems it appropriate. The Company's hearing request will stay the suspension of the Company's securities pending the hearing and a final determination by the panel. As part of its appeal, the Company will be required to provide the panel with a plan to regain compliance.  The Company's plan includes a commitment to effect a reverse stock split, if necessary.

"We have filed a definitive proxy statement requesting shareholder approval for a 1 for 5 reverse stock split to regain compliance," stated Kelvyn H. Cullimore, Jr., chairman and president of Dynatronics.  "With several positive developments taking place at the Company, including the recently announced introduction of our Dynatronics SolarisPlus product line and Quad7 products, we believe Dynatronics has a strong future and will be granted the time under our plan necessary to effect our reverse split in order to regain compliance with the rule."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 15, 2012; Conference Call set for 3:30 p.m. ET
2. Dynatronics Introduces New SolarisPlus Line of Therapy Products
3. Watson and Actavis Receive FTC Second Request
4. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
5. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
6. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
7. United States ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
8. United Kingdom ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
9. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
10. India ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
11. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... JOLLA, Calif. , Feb. 23, 2017 ... company leading the discovery and development of innovative medicines ... and full year 2016 financial results on Thursday, March ... will host a conference call and webcast on March ... fourth quarter and full year 2016 financial results and ...
(Date:2/23/2017)... -- ... Research and Markets has announced the addition of the "Global Antifungal ... to their offering. The Global Antifungal Drugs Market is ... decade to reach approximately $12.8 billion by 2025. ... given segments on global as well as regional levels presented in the ...
(Date:2/23/2017)... Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company ... and market advanced products and therapies for the Wound ... sectors of healthcare, today announced its record results for ... 2016. Full Year 2016 Highlights are: ... full year 2015 revenue ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... host a diverse symposium on “Doping in Sport: How the Culture Might ... Richter & Hampton LLP. The symposium will be held at Pepperdine University in ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in clinical trials, today announced that Premier Research, a leading clinical development service ... Clinical trials are becoming increasingly complex, due in part to an array of ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... the Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to ... autism spectrum disorder (ASD) to see films in an environment that accommodates their ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... of her Smiling Patriot program today with a new Indiegogo campaign ... dental care to homeless veterans in the Los Angeles area, either as a participating ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Thomas ... perseverance and disciplined exercise regime, the author was able to successfully recover. In “ ... all relevant information for various sources on the principals of massage, anatomy , ...
Breaking Medicine News(10 mins):